| 1. |
王軍, 韓春, 祝淑釵, 等. 胸段食管癌淋巴結轉移規律及其影響因素[J]. 中國腫瘤臨床, 2010, 37(2):90-93.
|
| 2. |
Rodriquez-Bigas M, Maamoun S, Weber TK, et al. Clinical significance of colorectal cancer:metastases in lymph nodes <5 mm in size[J]. Ann Surg Oncol, 1996, 3(2):124-130.
|
| 3. |
Yokota T, Saito T, Narushima Y, et al. Lymph-node staining with activated Carbon CH40:a new method for axillary lymph-node dissection in breast cancer[J]. Can J Surg, 2000, 43(3):191-196.
|
| 4. |
Okamoto K, Sawai K, Minato H, et al. Number and anatomical extent of lymph node metastases in gastric cancer:analysis using intra-lymph node injection of activatedcarbon particles (CH40)[J]. Jpn J Clin Oncol, 1999, 29(2):74-77.
|
| 5. |
傅駿, 郁寶銘, 卞國偉, 等. 納米碳標記在結直腸癌根治術中的應用[J]. 中華胃腸外科雜志, 2007, 10(增刊1):8-10.
|
| 6. |
Van Tongeren MJ, Kromhout H, Gardiner K. Trends in levels of inhalable dust exposure, exceedance and overexposure in the European carbon black manufacturing industry[J]. Ann Occup Hyg, 2000, 44(4):271-280.
|
| 7. |
Magrez A, Kasas S, Salicio V, et al. Cellular toxicity of carbonbased nanomaterials[J]. Nano Lett, 2006, 6(6):1121-1125.
|
| 8. |
Ito T, Hagiwara A, Takagi T, et al. Local administration of methotrexate bound to activated Carbon particles (MTX-CH) for treating cancers in mice[J]. Anticancer Res, 2003, 23(2B):1401-1404.
|
| 9. |
馬榮龍, 楊西鵬, 高樹孟, 等. 納米碳在結直腸癌根治術中的應用研究[J]. 吉林醫學, 2013, 34(26):5359-5360.
|
| 10. |
中國抗癌協會食管癌專業委員會. 食管癌規范化診療指南[M]. 北京:中國協和醫科大學出版社, 2011:21-28.
|
| 11. |
李佰營, 王直, 姬生威, 等. 納米碳示蹤技術在胃癌根治術中的應用[J]. 現代腫瘤醫學, 2012, 20(8):1673-1674.
|